{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Organ" : [ "uberon:UBERON:0006611" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Clinical trials to alter the course of beta-cell destruction after diagnosis usually consider the amount of residual insulin secretion after 1 or 2 years of therapy as the primary outcome measure to assess effectiveness.",
  "reading_complete" : "2020-07-28T12:02:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T12:01:24Z",
  "trigger" : "amount",
  "evidence" : [ "amount of residual insulin" ],
  "pmc_id" : "5033079",
  "score" : 0
}